Trial Profile

Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 06 Feb 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Amphotericin B (Primary) ; Amphotericin B; Flucytosine
Indications Cryptococcal meningitis
Focus Adverse reactions; Proof of concept; Registrational; Therapeutic Use
Acronyms EnACT
Sponsors Matinas BioPharma

Most Recent Events

22 Aug 2023 Results (n=121) published in the Clinical Infectious Diseases
22 Aug 2023 According to Matinas BioPharma media release, data from this study were presented in the IDSA Journal Clinical Infectious Diseases
29 Mar 2023 Status changed from active, no longer recruiting to completed.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com